Solution structure of leukemia inhibitory factor

Area of Science:

• Biochemistry
• Structural Biology
• Molecular Biophysics

Background:

• Leukemia inhibitory factor (LIF) is a cytokine crucial for cell survival and differentiation.
• Understanding LIF's structure is key to elucidating its receptor interactions and biological functions.
• Previous studies determined the crystal structure of murine LIF, providing a basis for comparison.

Purpose of the Study:

• To determine the solution structure of a murine-human chimera of leukemia inhibitory factor (LIF).
• To compare the solution structure with the existing crystal structure of murine LIF.
• To identify structural differences that may influence LIF receptor binding.

Main Methods:

• Multidimensional heteronuclear nuclear magnetic resonance (NMR) techniques were employed.
• Long-range interhelical nuclear Overhauser effects (NOEs) were used to define helix orientations.
• The solution structure was analyzed and compared to the crystal structure.

Main Results:

• The LIF chimera adopts a four-alpha-helix bundle structure in solution, with an up-up-down-down orientation.
• The overall topology is similar to the crystal structure of murine LIF.
• Significant differences were observed in the N-terminal region (peptide bond conformation) and the CD loop, which is near a receptor-binding site.

Conclusions:

• The solution structure of the LIF chimera provides insights into its conformational dynamics.
• Discrepancies between solution and crystal structures, particularly in the CD loop, are important for understanding high-affinity binding to the LIF receptor alpha-chain.
• Structural models of LIF receptor interactions should consider these solution-state differences.